Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty

BBraun Medical SAS140 enrolled

Overview

This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.

Study Type

OBSERVATIONAL

Enrollment

140

Conditions

Knee Arthroplasty

Interventions

Total Knee prothesis e motion PS ProDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient having signed informed consent * Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided * Patients willing to participate in a 5 years follow-up Exclusion Criteria: * Active or suspected infection * Tumor on the concerned knee * Patient vulnerable and under legal protection

Locations (1)

Groupe hospitalier Paris-St Joseph

Paris, France

RECRUITING

Outcomes

Primary Outcomes

Survival rate at 5 years of the e motion PS Pro

The endpoint is the revision of at least one of the prosthesis components. If a patient withdraws from the study for any reason, counts as the end date for the survival of the implant of the last day on which the implants were well known even in place.

Time frame: the survival rate will be evaluated 6-12 weeks; 1; 2; 3; 4 and 5 years after the knee arthroplasty

Central Contacts

François Boillot

CONTACT

144123357 fboillot@hpsj.fr

Boubker Zniber

CONTACT

144123357 bzniber@hpsj.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.